RT Journal Article
SR Electronic
T1 Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.18.20103283
DO 10.1101/2020.05.18.20103283
A1 Julián Olalla
A1 Ana M Correa
A1 M Dolores Martín-Escalante
A1 M Luisa Hortas
A1 María Jesús Martín-Sendarrubias
A1 Víctor Fuentes
A1 Gabriel Sena
A1 Javier García-Alegría
A1 on behalf the ROBLE group
YR 2020
UL http://medrxiv.org/content/early/2020/05/20/2020.05.18.20103283.abstract
AB Objective determine the percentage of healthcare workers (HCW) carrying SARS-CoV-2 in high exposure areas of the hospital.Design cross-sectional study during April 15–24th in Hospital Costa del Sol (Marbella, Spain), excluding HCW with previous COVID19.Setting hospital based, focused on patient care areas COVID19.Participants 498 subjects, 80% women. Participation was offered to all the HCW of Emergencies, Intensive Care and Anesthesia, Internal Medicine and Pneumology. Other units not directly involved in the care of these patients were offered to participate.Intervention naso and oropharyngeal PCR determination was performed together with IgG and IgM antibody determination by immunochromatography. On the day of sampling, a health questionnaire was answered, reporting symptoms on the same day and in the previous fourteen days.Main outcome measures percentage of HCW with positive PCR for SARS-CoV-2, percentage of HCW with positive IgG for SARS-CoV-2.Results Two individuals were detected with PCR for SARS-CoV-2 positive (0.4%). Both were asymptomatic on the day of sampling, but one of them had had a CoVID-19 compatible picture in the previous two weeks and had positive IgG and IgM; therefore, only one subject was truly asymptomatic carrier (0.2%). 9 workers with positive IgG (1.8%) were detected.Conclusions the prevalence of asymptomatic carriers among health workers of the services directly involved in the care of patients with CoVID-19 was very low in our center. This type of strategy can be one more tool in controlling the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been possible thanks to private donations for COVID19 research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available for investigators after publication